Cancer charities have condemned a decision not to licence a drug being trialled in our region which extends the life of women suffering the advanced stages of breast cancer.
The National Institute for Clinical Excellence - or NICE - says the drug "Perjeeta" isn't cost effective.
Perjeeta is currently being tested on women through the Christie Hospital in Manchester - but it isn't routinely available on the NHS.
Cancer charities and women taking the drug want NICE to reconsider .
Ashley Derricott reports.
More top news
Rochdale MP Simon Danczuk says his battle to expose abuse left him depressed and helped wreck his marriage.
Police are searching for three men after a victim suffered fractured eye sockets in an attack outside a club in Manchester city centre.
Singer Linda Nolan, who was accused of being a benefits cheat, says she was "scared to death" of appearing in court.